Dr. Walter Gaman from Executive Medicine of Texas on television - February 1st, 2013
http://www.emtexas.com Executive Medicine of Texas is dedicated to providing confidential medical services to busy and high-profile individuals just like you. Some of the services we offer include extensive half-day physical examinations, concierge medicine, inside-out makeovers, and athletic performance evaluations with strategy plans. Our goal is to keep you healthy and vibrant for years to come. We make a difference every day in the lives of our clients. Schedule your appointment now, so we can start making a difference for you.

By: ExecutiveMedicine1

See more here:

Dr. Walter Gaman from Executive Medicine of Texas on television - February 1st, 2013 - Video

Wake Forest School Of Medicine Ultrasounds- Boy Band Medley

By: Chris Post

See the article here:

Wake Forest School Of Medicine Ultrasounds- Boy Band Medley - Video

Touhou 9: Phantasmagoria of Flower View - Match Mode Shikieiki vs Medicine
Touhou 9: Phantasmagoria of Flower View Difficulty: Normal Characters: Shiki (Me) vs Medicine (com) --- Lags at a few points, but other than that, it #39;s okay.

By: #12480; #12524; #12531; #12460; #12540; #12471; #12450;

Read more here:

Touhou 9: Phantasmagoria of Flower View - Match Mode Shikieiki vs Medicine - Video

POMONA, CA--(Marketwire - Feb 1, 2013) - The College of Veterinary Medicine received a $300,000 grant from PetSmart Charities (www.petsmartcharities.org) to acquire, equip and operate a high-volume mobile spay/neuter vehicle.

"This is a significant contribution to our academic program that doubles the College's mobile capacity to address community needs in the Inland Empire and the LA basin," said College of Veterinary Medicine Dean Phillip Nelson, DVM, PhD. "The support of the VACS II by PetSmart Charities, and the contribution of personnel and medical supplies by WesternU College of Veterinary Medicine, will result in a partnership designed to provide a measurable impact on the population of unowned/unwanted animals in local communities, while providing valuable learning experiences for our students."

The vehicle, VACS II (Veterinary Ambulatory Community Service), will be a key component of the college's Shelter Medicine fourth-year rotation. VACS II, which is expected to begin operation in August 2013, will take two to three fourth-year CVM students to area shelters to perform about 30 spays and neuters per day.

"We're going to be doing high-volume spay and neuter with those students," said CVM Assistant Professor Frank Bossong, DVM. "By the time students get to their fourth year, they're pretty seasoned. They are well prepared to be performing spays and neuters on dogs and cats at this point in our curriculum. We'll really be making a bigger impact on the animal population at the shelters here in Southern California."

WesternU applied for a grant to build a second VACS dedicated to pediatric spays and neuters. VACS II is under construction and, when completed, will go out on Mondays, Wednesdays and Fridays.

University Specialty Vehicles Inc. in Perris, Calif., constructed CVM's first mobile unit, VACS I, said Eva Jaeger, RVT, who is working closely with the company again 10 years later. "Getting a second opportunity to perfect a job well done the first time is an exciting prospect for all involved," she said.

"The VACS II will further ensure that our graduates will be ready to do surgery on day one with their new employer," Bossong said. "As with the VACS I, this new mobile unit demonstrates WesternU's continued commitment to producing health professionals who embrace the idea of community service."

Read more:

PetSmart Charities(R) Grants $300,000 to College of Veterinary Medicine for Spay/Neuter Mobile Unit

Mission Trip to Honduras - School of Medicine - Loma Linda University
A student and professor from the School of Medicine at Loma Linda University traveled to Honduras to give medical care to the local community in El Venado.

By: LomaLindaU

Excerpt from:

Mission Trip to Honduras - School of Medicine - Loma Linda University - Video

JCI #39;s Conversations with Giants in Medicine: Jeffrey Friedman
Dr. Jeffrey Friedman, of Rockefeller University, has been at the center of discovery of the molecular determinants of why we eat what we eat and, more importantly, why we eat so much of what we eat. Over the last three decades, now almost daily in the media, alarm has been sounded about the growing obesity epidemic. Dr. Friedman has spent his research career engaged in the discovery and characterization of leptin, one of the most important hormones regulating appetite and hunger.

By: jclininvest

See the original post:

JCI's Conversations with Giants in Medicine: Jeffrey Friedman - Video

Juanita J. Halls, MD, UW Health Internal Medicine
Learn more: http://www.uwhealth.org

By: UWHealthWI

Read the original here:

Juanita J. Halls, MD, UW Health Internal Medicine - Video

Ann M. McBride, MD, UW Health Internal Medicine
Learn more: http://www.uwhealth.org

By: UWHealthWI

See the rest here:

Ann M. McBride, MD, UW Health Internal Medicine - Video

OVERLAND PARK, Kan., Jan. 31, 2013 /PRNewswire/ -- The National Operating Committee on Standards for Athletic Equipment (NOCSAE) today announced an agreement to fund $855,657 in sports medicine and concussion research. More than 85 percent of this total $727,669 specifically will focus on research to reduce athlete concussion, which is a cornerstone of NOCSAE's mission.

The NOCSAE board finalized the research funding agreement on Jan. 26, during the conclusion of the winter board meeting in Phoenix, Ariz.

NOCSAE approved $358,869 for the continued funding of three 2012 concussion-specific research grants. In addition the board tentatively approved $496,788 in new research grants, with $368,800 of that total focusing on concussion research.

"Scientific research is essential to advancing the safety of athletes of all ages and effectively addressing the issue of sports concussions," said Mike Oliver, NOCSAE executive director. "The approved research grants will support some of the top scientists and researchers in the world, and will continue to inform and evolve NOCSAE athletic equipment standards."

NOCSAE is an independent and nonprofit standard-setting body that aims to enhance athletic safety through scientific research and the creation of performance standards for protective equipment. The organization is the leading nongovernmental source for concussion-specific research funding in sports medicine and science. Since 1995 NOCSAE has devoted more than $7 million toward research by the foremost experts in sports medicine and science to develop and advance athlete safety.

More information on the 2013 grant recipients can be found at http://www.nocsae.org in the coming weeks.

About NOCSAENOCSAE, the National Operating Committee on Standards for Athletic Equipment, is an independent and nonprofit standard-setting body with the sole mission to enhance athletic safety through scientific research and the creation of performance standards for protective equipment. Formed in 1969, NOCSAE is a leading force in the effort to improve athletic equipment and, as a result, reduce injuries. NOCSAE efforts include the development of performance and test standards for football helmets, gloves and facemasks, baseball and softball batter's and catcher's helmets, baseballs and softballs, ice hockey helmets, soccer shin guards, lacrosse helmets and facemasks and polo helmets. NOCSAE is comprised of a board of directors representing stakeholders from a number of groups including consumer and end users, equipment manufacturers and reconditioners, athletic trainers, coaches, equipment managers, and academic and sports medicine associations. These diverse interests have joined forces in an attempt to arrive at a common goal of reducing sports-related injuries. NOCSAE is a nonprofit, charitable organization supported by individuals and organizations with an interest in athletics. For more information, please visit http://www.nocsae.org.

See the article here:

NOCSAE Agrees to Fund More Than $855,000 in Sports Medicine and Concussion Research

CHICAGO--(BUSINESS WIRE)--

For the last decade, Specialdocs Consultants, Inc. has been dedicated to successfully transitioning traditional medical practices to individually-designed concierge or personalized care models. During the past 10 years, Specialdocs has provided more than 100 physicians across the United Stateswith consulting, management and practice design services, along with financial processing, legal, and marketing support as they transition to a concierge practice, emphasizing personalized care.

Creating Specialdocs was my vision for allowing physicians to return to the heart of the practice of medicine - caring for their patients, notes Roberta Greenspan, Founder and President of Specialdocs Consultants, Inc. This model of care ensures that physicians are able to devote more time and resources exclusively to patient care rather than to the business of modern healthcare. Our doctors increase their average face time spent with patients from less than 10 minutes to 30 minutes or more for routine appointments.

As a seasoned healthcare executive and visionary with more than 30 years of professional experience, Greenspan founded and developed Specialdocs with the concept of bringing back patient-focused, high quality medical care to frustrated physicians and their equally frustrated patients.

As the firm celebrates its 10th anniversary, it is already focusing on the next 10 years and beyond. Specialdocs believes that every physicians practice is unique and should be designed to best serve the specific needs of patients in each individual practice. Across the county, year after year, our physicians tell us how we have changed their lives, giving them renewed enthusiasm for the clinical practice of medicine, says Greenspan. It is extremely rewarding that we have maintained longstanding relationships with our growing number of happy physician-clients.

With the adaptation of the Affordable Care Act and ACOs, our individually tailored model has continually been gaining traction, says Specialdocs Principal, Michael Friedlander. Now more than ever, physicians will need to explore their options as they navigate through new legislation and our countrys ever evolving healthcare system.

About:

Specialdocs is a medical practice consulting firm dedicated to converting traditional medical practices to personalized care or concierge models. Specialdocs is strongly invested in the concept of patient-focused medical care, working with each physician or physician group to return the physician-patient relationship to the forefront of medical services. Having successfully transitioned medical practices in 22 states across the country, their client panel has grown exclusively through satisfied physician referrals. For more information please call:847-432-4502or visit:www.specialdocs.com

Visit link:

Concierge Medicine Consulting Firm Celebrates a Decade of Personalized Care

The high cost of some western medicine is pushing more and more people to turn to alternative medicine. Jose Rodolfo Fierro is one of those people. He came to his local market in Juarez, Mexico to buy a natural herb known as cundeamor.

Im trying to get some medicine for a relative that lives in the States, El Paso. He told me to get some kind of medicine... He's a diabetic. He was told that if he was using this type of medicine he might get better. So he is willing to try, says Rodolfo Fierro.

Turns out, a lot of people in the borderland are willing to try natural herbs.

On both the U-S and Mexico side about 70 percent of the people in Juarez and El Paso use some sort of herbal medicine. That's more than double the national mainstream, says Dr. Armando Gonzalez-Stuart.

Gonzalez-Stuart works at El Paso Community College and specializes in the scientific application of herbal medicine. He says there are more than five 5,000 different medicinal plants in Mexico alone.

Walking through markets in Juarez, its easy to find plants used to treat nervous disorders, urinary problems and gastrointestinal conditions, just to name a few.

Chuchupate is the root of a plant. Its known as a very good anti-inflammatory.

Its good for the respiratory and gastrointestinal systems. And recent studies have found is be good for diabetes, says Dr. Gonzalez-Stuart.

Worldwide, only about 10 percent of all possible medicinal herbs have been studied. Some of the more common include echinacea, chamomile and St. John's wort.

It's estimated the vast majority of those taking alternative medicine in the borderland fail to tell their doctor. Some don't think it's important to share the information, while others fear their physician may dismiss the practice.

Go here to read the rest:

Special Assignment: Dangers of herbal medicine

Public release date: 31-Jan-2013 [ | E-mail | Share ]

Contact: Lauren Woods Law2014@med.cornell.edu 646-317-7401 Weill Cornell Medical College

NEW YORK (Jan. 31, 2013) -- Recognizing that medicine is not "one size fits all," Weill Cornell Medical College and NewYork-Presbyterian Hospital have created the pioneering Institute for Precision Medicine at Weill Cornell and NewYork-Presbyterian/Weill Cornell Medical Center. This new, cutting-edge translational medicine research hub will explore the new frontier of precision medicine, offering optimal targeted, individualized treatment based on each patient's genetic profile. The institute's new genomic research discoveries will help develop novel, personalized medical therapies to be tested in innovative clinical trials, while also building a comprehensive biobank to improve research and patient care.

The Institute for Precision Medicine will be led by Dr. Mark Rubin, a renowned pathologist and prostate cancer expert who uses whole genomic sequencing in his laboratory to investigate DNA mutations that lead to disease, particularly prostate cancer. Dr. Rubin currently serves as vice chair for experimental pathology, director of Translational Research Laboratory Services, the Homer T. Hirst III Professor of Oncology, professor of pathology and laboratory medicine and professor of pathology in urology at Weill Cornell and is a pathologist at NewYork-Presbyterian/Weill Cornell.

Dr. Rubin and his team seek to replace the traditional one-size-fits-all medicine paradigm with one that focuses on targeted, individualized patient care using a patient's own genetic profile and medical history. Physician-scientists at the institute will seek to precisely identify the genetic influencers of a patient's specific illness -- such as cancer, cardiovascular disease, neurodegenerative disease and others -- and use this genetic information to design a more-effective course of treatment that targets those specific contributing factors. Also, genomic analyses of tumor tissue will enable researchers to help patients with advanced disease and no current treatment options, as well as to isolate the causes of drug resistance in patients who stop responding to treatments, redirecting them to more successful therapies.

Preventive precision medicine will also be a key initiative at the institute, allowing physician-scientists to help identify a patient's risk of diseases and take necessary steps to aid in its prevention through medical treatment and/or lifestyle modification. In addition, the Institute for Precision Medicine will leverage an arsenal of innovative genomic sequencing, biobanking and bioinformatics technology to transform the existing paradigm for diagnosing and treating patients.

"This institute will revolutionize the way we treat disease, linking cutting-edge research and next-generation sequencing in the laboratory to the patient's bedside," Dr. Rubin says. "We will use advanced technology and the collective wealth of knowledge from our clinicians, basic scientists, pathologists, molecular biologists and computational biologists to pinpoint the molecular underpinnings of disease -- information that will spur the discovery of novel treatments and therapies. It's an exciting time to be involved in precision medicine and I look forward to advancing this game-changing field of medicine."

"Precision medicine is the future of medicine, and its application will help countless patients," says Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. "The Institute for Precision Medicine, with Dr. Rubin's expertise and strong leadership, will accelerate our understanding of the human genome, provide key insights into the causes of disease and enable our physician-scientists to translate this knowledge from the lab to the clinical setting to help deliver personalized treatments to the sickest of our patients."

Three main resources will facilitate the institute's groundbreaking precision medicine work: genomics sequencing, biobanking and bioinformatics. Weill Cornell and NewYork-Presbyterian will invest in state-of-the-art technology to conduct sequencing, a more expansive biobank for all patient specimens and tissue samples and dedicated bioinformaticians who will closely analyze patient data, searching for genetic mutations and other abnormalities to identify and target with treatment.

"The Institute for Precision Medicine will enable our doctors to tailor effective treatments for individual patients and also predict the diseases that are likely to affect a patient long before they develop," says Dr. Steven J. Corwin, CEO of NewYork-Presbyterian Hospital. "By harnessing the full potential of our enhanced understanding of the human genome, and extending its reach into the clinical realm, the institute will transform patient care at NewYork-Presbyterian/Weill Cornell Medical Center and beyond."

Go here to see the original:

New Institute for Precision Medicine created at Weill Cornell and NewYork-Presbyterian

Medicine Today in Armenian: Diabetes
Medicine Today Tuesday, Jan. 29, 2013 Diabetes Guest: Sam Malayan, MD, Board Certified Internist and Endocrinologist Hosted by Dr. Sahag Arslanian

By: MedicineTodayShow

See the article here:

Medicine Today in Armenian: Diabetes - Video

House Medicine FT Lucy Mcleod - Fall Down [Music Video] @HouseMedicine
We linked up with House Medicine to bring you this visuals for this epic track. @HouseMedicine @LucyMacMusic http://www.linkuptv.co.uk http LIKE us on Facebook: http://www.facebook.com Follow us on Twitter: twitter.com

By: linkuptvuk

Follow this link:

House Medicine FT Lucy Mcleod - Fall Down [Music Video] @HouseMedicine - Video

The University of Otago has signed an agreement with the University of Medicine (1) in Myanmar (also known as Burma) to collaborate on research, training, and capacity building in areas including infectious disease.

Myanmar is the second largest country in Southeast Asia and home to more than 60 million people. In 2008 Myanmar embarked on a process of reforms towards a liberal democracy, a mixed economy, and reconciliation. These developments have opened opportunities for increased engagement with international partners, including with New Zealand. Based in Yangon, the University of Medicine (1) is Myanmars oldest medical school. University of Medicine (1) plays a major role in the training of medical doctors and allied health sciences professionals.

The Rector of University of Medicine (1), Professor Than Cho, says "we are delighted to be embarking on this new relationship with colleagues at the University of Otago.

"International partnerships help to strengthen our ability to address pressing national health needs. Much can be achieved by collaboration between the oldest and most distinguished universities in Myanmar and New Zealand."

University of Otago Vice-Chancellor Professor Harlene Hayne welcomed the initiative saying that universities have a duty to assist in reducing such health disparities worldwide through research, education, and service.

"I am excited that Otago is able to contribute to international progress by partnering with a major provider of health education, research, and service in Myanmar," Professor Hayne says.

Professor John Crump, McKinlay Professor of Global Health and Co-Director, Centre for International Health, says substantial, long-term collaborations with institutions in low-resource settings are the fundamental building blocks of global health initiatives by universities based in developed countries.

"These form the basis for meaningful exchange and activities in the areas of research, teaching, and service with a range of benefits for both partners," he says.

The collaboration between the University of Medicine (1) and the University of Otago will have an initial focus on research, training, and capacity building on infectious diseases and medical microbiology. However, it is anticipated that the relationship will expand over time to engage with a range of disciplines across the institutions both within and beyond the health sciences.

Read more:

Otago partners with University of Medicine (1) in Myanmar

FAIRFIELD, CA--(Marketwire - Jan 30, 2013) - ChemSW, Inc. will be exhibiting at the upcoming Molecular Medicine Tri-Con 2013 Conference in San Francisco, CA from February 11-15, 2013.

ChemSW will be highlighting CISPro, their industry-leading chemical inventory management system that enables organizations to track and manage chemicals from receipt through disposal.CISPro delivers the ability to maintain a real-time listing of all the chemicals in the facility, generate reports, and quickly access hazard information during an emergency. ChemSW will be demonstrating CISPro daily during the conference.

In addition, ChemSW will highlight their unique new Safety Inspection Live solution that enables users to record safety inspections using the most popular mobile devices such as smartphones, tablets, and laptops to manage data in real-time.By eliminating duplicate transcription processes and enabling users to enter inspection data at the time of inspection, Safety Inspection Live assures greater data accuracy and inspection efficiency.

The 20th Molecular Medicine Tri-Con 2013 conference is a leading conference and exposition for applied science and technology that delivers more than 250 presentations in 12 conference tracks that cover five key topics: diagnostics, therapeutics, clinical, cancer, and informatics. For details, visit http://www.triconference.com/.

For details about CISPro, visit http://www.chemsw.com/Software-and-Solutions/Chemical-Inventory.aspx or call (707) 864-0845.

About ChemSWFounded over two decades ago, ChemSW is a leading provider of chemical and biochemical inventory management systems, MSDS systems and other chemistry laboratory software and services. ChemSW's wide range of products enable organizations to efficiently manage assets and processes. ChemSW supports over 15,000 customers in more than 40 countries throughout the world.For more information, visit http://www.ChemSW.com or call +1 707-864-0845.

The rest is here:

ChemSW to Demonstrate CISPro at Upcoming Molecular Medicine Tri-Con 2013 Conference

WALTHAM, Mass., Jan. 30, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced the closing of its previously announced public offering of 6,000,000 shares of its common stock, as well as 900,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriter.

The shares were sold at the public offering price of $2.00 per share and the company estimates the aggregate net proceeds to the company will be approximately $12.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses.

Lazard Capital Markets LLC acted as the sole book-running manager for the offering.

The shares were sold by means of BG Medicine's existing shelf registration statement on Form S-3, a prospectus and related prospectus supplement, all as filed with the Securities and Exchange Commission (the "SEC"). Copies of the prospectus supplement may be obtained from the offices of Lazard Capital Markets LLC, 30 Rockefeller Plaza, New York, NY 10020 or via telephone at (800) 542-0970.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities of BG Medicine, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About BG Medicine

BG Medicine, Inc. (BGMD) is a diagnostics company focused on the development and commercialization of novel cardiovascular tests to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. The Company has two products: the BGM Galectin-3(R) test for use in patients with chronic heart failure is available in the United States and Europe; and the CardioSCORE(TM) test for the risk prediction of major cardiovascular events will be launched in Europe in the first half of 2013. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.bg-medicine.com and http://www.galectin-3.com.

The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10352

Cautionary Statement Regarding Forward-Looking Statements

This communication includes forward-looking statements regarding events, trends and business prospects, which may affect BG Medicine's future operating results and financial position. Such statements, including, but not limited to, those regarding BG Medicine's estimates of its approximate net proceeds from the public offering and expenses payable in connection with the public offering, involve known and unknown risks that relate to BG Medicine's future events or future financial performance and the actual results could differ materially from those discussed in this communication. Risks and uncertainties that may cause BG Medicine's actual results to differ materially from those discussed in this communication can be found in the "Risk Factors" section of BG Medicine's prospectus supplement filed on January 25, 2013 relating to the public offering, its Current Report on Form 8-K filed on January 24, 2013, and the other filings BG Medicine periodically makes with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof, and BG Medicine assumes no responsibility to update or revise any forward-looking statements contained in this communication to reflect events, trends or circumstances after the date of this communication.

Visit link:

BG Medicine, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option

Medicine ball squat
Balance on the medicine ball. Bend at the knees, sitting butt back. Press up, squeezing butt tight. If you use the dumbbells, hold them at the shoulders with the palms facing in. Squat down holding dumbbells at the chest. As you stand, press the dumbbells overhead turning the dumbbells out.

By: Michele Lumadue

Read this article:

Medicine ball squat - Video

daughters medicine

By: PaNDKREW

Read the original:

daughters medicine - Video

WASHINGTON, Jan. 29, 2013 /PRNewswire/ --The Society for Participatory Medicine (SPM), an organization devoted to advancing communication and cooperation among all health care stakeholders, has chosen Barbara L. Kornblau as its first executive director. Her appointment marks a milestone for the society, founded in 2009 as a partnership among empowered patients ("e-patients"), health professionals and the systems that support them.

(Photo: http://photos.prnewswire.com/prnh/20130129/PH49607LOGO)

"We are very excited by the extensive experience Barbara brings to the society," said Sarah Krg, SPM's president. "Her background working in health care and her expertise in law, policy, academia and advocacy will all reinforce the society's mission of catalyzing collaborative partnerships to optimize health and health care."

Kornblau is an attorney and licensed occupational therapist, with both advocacy and academic experience. She was dean of the School of Health Professions and Studies at the University of Michigan, Flint and professor of Occupational Therapy and Public Health at Nova Southeastern University.

A former Robert Wood Johnson Health Policy Fellow for U.S. Senators Tom Harkin and Jay Rockefeller, Kornblau has also served as government relations consultant for Special Olympics, International. In addition, she is the founder of the Coalition for Disability Health Equity and has published several books and articles. She holds a B.S. from the University of Wisconsin-Madison, and a J.D. from the University of Miami. She is a member of the Florida Bar, the United States Supreme Court Bar, and several appellate court bars.

"Participatory medicine will play a key role in improving our nation's health," Kornblau said. "On a personal and a professional level, I am proud and excited at the opportunity to help this premier organization, dedicated to bringing together health care providers, patients, and other stakeholders, to make better health care decisions."

The Society for Participatory Medicine is open to both individual and institutional members and has a governing board comprised of both clinicians and patients. It publishes the Journal of Participatory Medicine, the only peer-reviewed publication devoted to advancing the understanding and practice of participatory medicine, and the popular blog, e-patients.net.

For more information, see: http://participatorymedicine.org/

This press release was issued through eReleases Press Release Distribution. For more information, visit http://www.ereleases.com.

See more here:

Society for Participatory Medicine Names Barbara Kornblau as its First Executive Director